Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma
BackgroundAmong malignant tumors, hepatocellular carcinoma (HCC) is both prevalent and highly lethal. Most patients with advanced-stage liver cancer have a poor prognosis. Death-associated protein 3 (DAP3) is reportedly related to tumors and may hold g…